Figure 3
Figure 3. The frequency of antigen-specific Tregs in transplant recipients decreases immediately after HSCT. Donor mice (Thy1.2+/+) with a 10-day established tumor burden received 2.5 × 106 CD4+-enriched HA-specific T cells (Thy1.1+/1.2+). At 19 days after T-cell transfer, donor mice were killed, and their spleens and LNs were harvested and T-cell–enriched to be transferred into transplant recipients. Recipients (Thy1.1+/+) were challenged with 1 × 106 A20HA intravenously 10 days prior to HSCT and underwent transplantation as described in “Methods.” Half of the transplant recipients received daily injections of 10 μg/mouse IL-2 intraperitoneally. The frequency of HA-specific CD4+ T cells (Thy1.1+1.2+) expressing Foxp3 was determined by flow cytometry in the graft and in recipients killed 1 and 2 weeks after transplantation. Data represent means plus or minus SE.

The frequency of antigen-specific Tregs in transplant recipients decreases immediately after HSCT. Donor mice (Thy1.2+/+) with a 10-day established tumor burden received 2.5 × 106 CD4+-enriched HA-specific T cells (Thy1.1+/1.2+). At 19 days after T-cell transfer, donor mice were killed, and their spleens and LNs were harvested and T-cell–enriched to be transferred into transplant recipients. Recipients (Thy1.1+/+) were challenged with 1 × 106 A20HA intravenously 10 days prior to HSCT and underwent transplantation as described in “Methods.” Half of the transplant recipients received daily injections of 10 μg/mouse IL-2 intraperitoneally. The frequency of HA-specific CD4+ T cells (Thy1.1+1.2+) expressing Foxp3 was determined by flow cytometry in the graft and in recipients killed 1 and 2 weeks after transplantation. Data represent means plus or minus SE.

Close Modal

or Create an Account

Close Modal
Close Modal